Cargando…

Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice

BACKGROUND: Atherosclerosis is a chronic disease that is closely related to inflammation and macrophage apoptosis, which leads to secondary necrosis and proinflammatory responses in advanced lesions. Caspase‐activated DNase (CAD) is a double‐strand specific endonuclease that leads to the subsequent...

Descripción completa

Detalles Bibliográficos
Autores principales: Chao, Meng‐Lin, Guo, Junhong, Cheng, Wen‐Lin, Zhu, Xue‐Yong, She, Zhi‐Gang, Huang, Zan, Ji, Yong, Li, Hongliang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210397/
https://www.ncbi.nlm.nih.gov/pubmed/28007744
http://dx.doi.org/10.1161/JAHA.116.004362
_version_ 1782490878347051008
author Chao, Meng‐Lin
Guo, Junhong
Cheng, Wen‐Lin
Zhu, Xue‐Yong
She, Zhi‐Gang
Huang, Zan
Ji, Yong
Li, Hongliang
author_facet Chao, Meng‐Lin
Guo, Junhong
Cheng, Wen‐Lin
Zhu, Xue‐Yong
She, Zhi‐Gang
Huang, Zan
Ji, Yong
Li, Hongliang
author_sort Chao, Meng‐Lin
collection PubMed
description BACKGROUND: Atherosclerosis is a chronic disease that is closely related to inflammation and macrophage apoptosis, which leads to secondary necrosis and proinflammatory responses in advanced lesions. Caspase‐activated DNase (CAD) is a double‐strand specific endonuclease that leads to the subsequent degradation of chromosome DNA during apoptosis. However, whether CAD is involved in the progression of atherosclerosis remains elusive. METHODS AND RESULTS: CAD (−/−)ApoE(−/−) and ApoE(−/−) littermates were fed a high‐fat diet for 28 weeks to develop atherosclerosis. Human specimens were collected from coronary heart disease (CHD) patients who were not suitable for transplantation. CAD expression was increased in the atheromatous lesions of CHD patients and high‐fat diet‐treated ApoE‐deficient mice. Further investigation demonstrated that CAD deficiency inhibited high‐fat diet‐induced atherosclerosis, as evidenced by decreased atherosclerotic plaques, inhibited inflammatory response, and macrophage apoptosis, as well as enhanced stability of plaques in CAD (−/−)ApoE(−/−) mice compared to the ApoE(−/−) controls. Bone marrow transplantation verified the effect of CAD on atherosclerosis from macrophages. Mechanically, the decrease in the phosphorylated levels of mitogen‐activated protein kinase (MAPK) kinase/extracellular signal‐regulated kinase 1 and 2 (MEK‐ERK1/2) that resulted from CAD knockout and the activation of nuclear factor kappa B signaling mediated by CAD stimulation that was suppressed by inhibiting ERK1/2 phosphorylation revealed the potential association between the role of CAD in atherosclerosis and the MAPK signaling pathway. CONCLUSIONS: In conclusion, CAD deficiency protects against atherosclerosis through inhibiting inflammation and macrophage apoptosis, which is partially through inactivation of the MEK‐ERK1/2 signaling pathway. This finding provides a promising therapeutic target for treating atherosclerosis.
format Online
Article
Text
id pubmed-5210397
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-52103972017-01-05 Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice Chao, Meng‐Lin Guo, Junhong Cheng, Wen‐Lin Zhu, Xue‐Yong She, Zhi‐Gang Huang, Zan Ji, Yong Li, Hongliang J Am Heart Assoc Original Research BACKGROUND: Atherosclerosis is a chronic disease that is closely related to inflammation and macrophage apoptosis, which leads to secondary necrosis and proinflammatory responses in advanced lesions. Caspase‐activated DNase (CAD) is a double‐strand specific endonuclease that leads to the subsequent degradation of chromosome DNA during apoptosis. However, whether CAD is involved in the progression of atherosclerosis remains elusive. METHODS AND RESULTS: CAD (−/−)ApoE(−/−) and ApoE(−/−) littermates were fed a high‐fat diet for 28 weeks to develop atherosclerosis. Human specimens were collected from coronary heart disease (CHD) patients who were not suitable for transplantation. CAD expression was increased in the atheromatous lesions of CHD patients and high‐fat diet‐treated ApoE‐deficient mice. Further investigation demonstrated that CAD deficiency inhibited high‐fat diet‐induced atherosclerosis, as evidenced by decreased atherosclerotic plaques, inhibited inflammatory response, and macrophage apoptosis, as well as enhanced stability of plaques in CAD (−/−)ApoE(−/−) mice compared to the ApoE(−/−) controls. Bone marrow transplantation verified the effect of CAD on atherosclerosis from macrophages. Mechanically, the decrease in the phosphorylated levels of mitogen‐activated protein kinase (MAPK) kinase/extracellular signal‐regulated kinase 1 and 2 (MEK‐ERK1/2) that resulted from CAD knockout and the activation of nuclear factor kappa B signaling mediated by CAD stimulation that was suppressed by inhibiting ERK1/2 phosphorylation revealed the potential association between the role of CAD in atherosclerosis and the MAPK signaling pathway. CONCLUSIONS: In conclusion, CAD deficiency protects against atherosclerosis through inhibiting inflammation and macrophage apoptosis, which is partially through inactivation of the MEK‐ERK1/2 signaling pathway. This finding provides a promising therapeutic target for treating atherosclerosis. John Wiley and Sons Inc. 2016-12-22 /pmc/articles/PMC5210397/ /pubmed/28007744 http://dx.doi.org/10.1161/JAHA.116.004362 Text en © 2016 The Authors. Published on behalf of the American Heart Association, Inc., by Wiley Blackwell. This is an open access article under the terms of the Creative Commons Attribution‐NonCommercial‐NoDerivs (http://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Original Research
Chao, Meng‐Lin
Guo, Junhong
Cheng, Wen‐Lin
Zhu, Xue‐Yong
She, Zhi‐Gang
Huang, Zan
Ji, Yong
Li, Hongliang
Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice
title Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice
title_full Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice
title_fullStr Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice
title_full_unstemmed Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice
title_short Loss of Caspase‐Activated DNase Protects Against Atherosclerosis in Apolipoprotein E–Deficient Mice
title_sort loss of caspase‐activated dnase protects against atherosclerosis in apolipoprotein e–deficient mice
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5210397/
https://www.ncbi.nlm.nih.gov/pubmed/28007744
http://dx.doi.org/10.1161/JAHA.116.004362
work_keys_str_mv AT chaomenglin lossofcaspaseactivateddnaseprotectsagainstatherosclerosisinapolipoproteinedeficientmice
AT guojunhong lossofcaspaseactivateddnaseprotectsagainstatherosclerosisinapolipoproteinedeficientmice
AT chengwenlin lossofcaspaseactivateddnaseprotectsagainstatherosclerosisinapolipoproteinedeficientmice
AT zhuxueyong lossofcaspaseactivateddnaseprotectsagainstatherosclerosisinapolipoproteinedeficientmice
AT shezhigang lossofcaspaseactivateddnaseprotectsagainstatherosclerosisinapolipoproteinedeficientmice
AT huangzan lossofcaspaseactivateddnaseprotectsagainstatherosclerosisinapolipoproteinedeficientmice
AT jiyong lossofcaspaseactivateddnaseprotectsagainstatherosclerosisinapolipoproteinedeficientmice
AT lihongliang lossofcaspaseactivateddnaseprotectsagainstatherosclerosisinapolipoproteinedeficientmice